Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
518
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics
Private Equity | Healthcare

TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

Learn more
Fysicon B.V. has been acquired by Canon Medical Systems
Healthcare

Fysicon B.V. has been acquired by Canon Medical Systems

Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.

Learn more
Ambry Genetics Corporation has been acquired by Konica Minolta, Inc.
Healthcare | TMT

Ambry Genetics Corporation has been acquired by Konica Minolta, Inc.

Ambry Genetics Corporation (Ambry), a clinical diagnostics testing services provider, has been acquired by Konica Minolta, Inc.

Learn more
“Oaklins’ team in Los Angeles understood our culture and history of innovation, and through the Konica Minolta partnership we will have the resources, technology and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness.”

Aaron Elliott

CEO, Ambry Genetics Corporation

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=JP&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Realigning, raising, reinventing: mid-market M&A in motion

QUARTERLY M&A ACTIVITY: In Q2 2025, we facilitated 47 transactions, driving mid-market transactions in TMT, energy and more. Explore trends in cross-border and hear from our clients.

Learn more

Talk to our local advisor

Ikki Mizuno

Director
Tokyo, Japan
Oaklins Maxus Corporate Advisory

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital